Navigation Links
Number of Testosterone Therapy Lawsuits More than Doubles in Two-Week Period, Baron and Budd Reports
Date:7/18/2014

DALLAS (PRWEB) July 18, 2014

The number of lawsuits filed involving plaintiffs claiming they suffered adverse health affects after taking drugs associated with testosterone therapy more than doubled from June 6-16, 2014, reports the national law firm of Baron and Budd. On June 6 there were 45 such lawsuits pending in the U.S. District Court of Illinois, but by June 16 there were nearly 100 lawsuits pending. (In re: Testosterone Replacement Therapy Product Liability Litigation - MDL No. 2545)

A Transfer Order was issued on June 6 by the U.S. Judicial Panel on Multidistrict Litigation (MDL), to consolidate lawsuits to facilitate more efficient progression of the cases. According to the Order, thousands more testosterone lawsuits could potentially be filed. (http://www.jpml.uscourts.gov/sites/jpml/files/MDL-2545-Initial_Transfer-05-14.pdf) Plaintiffs in the cases are claiming that the testosterone drugs they took caused a wide range of cardiovascular issues, including strokes and heart attacks.

The U.S. Food and Drug Administration announced on January 31, 2014 that it was undergoing a review of the medications in the wake of study results that showed a potential link between the drugs and the cardiovascular issues. These studies indicated that men taking testosterone therapy medications faced a higher chance of developing health problems than men who did not take the drugs. (http://www.fda.gov/Drugs/DrugSafety/ucm383904.htm)

On June 20, 2014, the FDA announced it would require manufacturers of testosterone therapy medications to add a warning to their labeling regarding the potential formation of blood clots. The higher risk, according to the agency, is due to a condition known as polycythemia, which is an increase in red blood cell count. Testosterone drugs have been linked to the condition.

“This momentum in testosterone therapy lawsuits is an indication that the FDA is moving in the right direction with respect to making sure the public is warned,” said Stephen Blackburn attorney at the national law firm of Baron and Budd. “We hope the FDA will consider the number of clients alleging injuries as a result of testosterone replacement therapy and take an even closer look at the widespread use of testosterone.”

Please get in touch with the national law firm of Baron and Budd if you or someone close to you suffered a stroke, blood clots or other cardiovascular problems after undergoing testosterone therapy. Call Baron and Budd at 866-472-9108 or visit our website to learn more: http://baronandbudd.com/areas-of-practice/pharmaceuticals/testosterone-therapy/.

ABOUT BARON AND BUDD

The law firm of Baron and Budd, with offices in Dallas, Baton Rouge, Austin and Los Angeles, is a nationally recognized law firm with over 35 years of “Protecting What’s Right” for people, communities and businesses harmed by negligence. Baron & Budd’s size and resources enable the firm to take on large and complex cases. The firm represents individuals, governmental and business entities in areas as diverse as water contamination, Gulf oil spill, Qui Tam, California Proposition 65 violations, unsafe drugs and medical devices, Chinese drywall, deceptive advertising, consumer financial fraud, securities fraud and asbestos cancers such as mesothelioma.

Read the full story at http://www.prweb.com/releases/2014/07/prweb12017016.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. CDC Finds Maine With Highest Number of Opiate Prescription Users
2. Long-term care must be improved to aid rising numbers with dementia, study finds
3. When it comes to numbers, culture counts
4. Safety in numbers: Moderate drinking in a group reduces attraction to risk
5. Study shows young men increasingly outnumber young women in rural Great Plains
6. Mass number-crunching may help crack Alzheimers disease code
7. Atypical form of Alzheimers disease may be present in a more widespread number of patients
8. Scientists discover a number of novel genetic defects which cause oesophageal cancer
9. Concerning number of kids have elevated cholesterol
10. Number of babies mom has may play role in future cardiovascular health
11. RI Hospital: Number of patients admitted with antibiotic-resistant infections is rising
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... ... February 12, 2016 , ... The ThedaCare ... San Francisco General Hospital on April 5-7. The series is a multi-day, multi-workshop ... habits. The workshops cover a broad range of topics, including coaching skills, the ...
(Date:2/12/2016)... ... 2016 , ... Fisher House Foundation Chairman and CEO Kenneth Fisher joined Governor ... Alliance president Scott Bensing, and Peggy Kearns Director, VA Southern Nevada Healthcare System yesterday ... This will be the first Fisher House in Nevada, and will provide free lodging ...
(Date:2/12/2016)... ... ... Vail knee specialist Robert LaPrade, MD, PhD was named one of ... of physicians establishing, leading and partnering with ambulatory surgery centers across the United States. ... also known as an ASC, is a modern health care facility focused on providing ...
(Date:2/12/2016)... ... ... Donor Network West, the organ procurement organization that heals lives through organ ... Regional Medical Center. Under the collaboration, the first of its kind, specific organ donors ... certain time frame for donor families for the recovery of organs. , Organ ...
(Date:2/12/2016)... ... 12, 2016 , ... J Thomas & Associates Insurance Agency, ... to act as Agents of Change in the community, announces a new partnership ... to fulfill immediate needs and help them move into permanent housing. Donations to ...
Breaking Medicine News(10 mins):
(Date:2/11/2016)... , Feb. 11, 2016 The primary goal ... future adoption patterns on the usage of liquid biopsy. ... following: - Timeframe of liquid biopsy adoption ... cfDNA and Evs—by organization type - Sample inflow to ... blood, saliva, stool, serum, and so on. - Correlation ...
(Date:2/11/2016)... 2016 PRO-DEX, INC. (NasdaqCM: PDEX) today announced financial ... 2015. The Company also filed its Quarterly Report on Form ... the Securities and Exchange Commission today. --> ... --> --> Net sales for ... or 95%, to $5.4 million from $2.8 million for the ...
(Date:2/11/2016)... , Feb. 11, 2016  Kindred Biosciences, Inc. ... saving and improving the lives of pets, today announced ... of the New Animal Drug Application (NADA) for Zimeta™ ... field study (KB0120) of Zimeta for the control of ... Company. --> --> ...
Breaking Medicine Technology: